Experiment 69359
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Melissa officinalis (LAMIACEAE) |
| Citation | AKHONDZADEH,S: NOROOZIAN,M: MOHAMMADI,M: OHADINIA,S: JAMSHIDI,AH: KHANI,M:. (2003). MELISSA OFFICINALIS EXTRACT IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE: A DOUBLE BLIND, RANDOMISED, PLACEBO CONTROLLED TRIAL.. 74(7) |
| Amount utilized | |
| Compound isolated | |
| Disease | RECORDED. MELISSA OFFICINALIS EXTRACT IS OF VALUE IN THE MANAGEMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE AND HAS A POSITIVE EFFECT ON AGITATION IN SUCH PATIENTS. CLINICAL DEMENTIA RATING (CDR) WERE RANDOMISED TO PLACEBO OR FIXED DOSE OF MELISSA OFFICINALIS EXTRACT. THE MAIN EFFICACY MEASURES WERE THE CHANGE IN THE ADAS-COG AND COR-SB SCORES COMPARED WITH BASELINE SIDE EFFECTS WERE SYSTEMATICALLY CENTRES IN TEHRAN, IRAN. PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE AGED BETWEEN 65 AND 80 YEARS (N=42; 18 WOMEN, 24 MEN) WITH A SCORE OF >12 ON THE COGNITIVE SUBSCALE OF ALZHEIMER'S DISEASE ASSESSMENT SCALE (ADAS-COG) AND <2 ON THE A STUDY TO ASSESS THE EFFICACY AND SAFETY OF MELISSA OFFICINALIS EXTRACT USING A FIXED DOSE (60DROPS/DAY) IN PATIENTS WITH MILD TO MOCERATE ALZHEIMER'S DISEASE. A FOUR MONTH, PARALLEL GROUP, PLACEBO CONTROLLED TRIAL UNDERTAKEN IN THREE |
| Dose amount | 3.0 ML |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HYDRO-ALCOHOLIC EXT |
| Gender | GIVEN TO BOTH SEXES |